The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

13 articles for PB Timmermans


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives.EBI
E. I. Du Pont De Nemours And
The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives.EBI
E. I. Du Pont De Nemours
alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs.EBI
TBA
Discovery of INT131: a selective PPAR¿ modulator that enhances insulin sensitivity.EBI
Amgen
Potent non-benzoquinone ansamycin heat shock protein 90 inhibitors from genetic engineering of Streptomyces hygroscopicus.EBI
Kosan Biosciences
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.EBI
Dupont Pharmaceuticals
Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.EBI
TBA
 
Balanced angiotensin II receptor antagonists. III. The effects of substitution at the imidazole 5-position.EBI
TBA
 
Balanced angiotensin II receptor antagonists. II.1,2 4-aminomethyl- and acylaminomethylimidazolesEBI
TBA
 
Balanced angiotensin II receptor antagonists. I. The effects of biphenyl “ortho”-substitution on AT1/AT2 affinitiesEBI
TBA
 
Imidazolinones as nonpeptide angiotensin II receptor antagonistsEBI
TBA
A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site.EBI
Dupont Pharmaceuticals
Balanced AT1/AT2 receptor antagonists. 4. XR510 and related 5-(3-amidopropanoyl)imidazoles possessing equal affinity for the AT1 and AT2 receptors.EBI
Dupont Pharmaceuticals